Literature DB >> 33844588

What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring.

Rodolfo J Galindo1,2,3, Christopher G Parkin4, Grazia Aleppo5, Anders L Carlson6,7,8,9, Davida F Kruger10, Carol J Levy11,12, Guillermo E Umpierrez13,14, Janet B McGill15.   

Abstract

Numerous studies have demonstrated the clinical value of continuous glucose monitoring (CGM) in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for CGM coverage required by the Centers for Medicare & Medicaid Services (CMS) ignore conclusive evidence that supports CGM use in various diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the CMS eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.

Entities:  

Keywords:  Centers for Medicare & Medicaid Services; Continuous glucose monitoring; Insurance coverage; Type 1 diabetes; Type 2 diabetes

Mesh：

Substances：

Year:  2021        PMID： 33844588      PMCID： PMC8501458          DOI： 10.1089/dia.2021.0107

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN： 1520-9156            Impact factor:   6.118


  66 in total

1.  ONE-YEAR TIME ANALYSIS IN AN ACADEMIC DIABETES CLINIC: QUANTIFYING OUR BURDEN.

Authors:  Peter Huynh; Andrea Toulouse; Irl B Hirsch
Journal:  Endocr Pract       Date:  2018-03-02       Impact factor: 3.443

2.  Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.

Authors:  Kamlesh Khunti; Saud Alsifri; Ronnie Aronson; Maja Cigrovski Berković; Catherine Enters-Weijnen; Tom Forsén; Gagik Galstyan; Petronella Geelhoed-Duijvestijn; Margalit Goldfracht; Helge Gydesen; Rahul Kapur; Nebojsa Lalic; Bernhard Ludvik; Erik Moberg; Ulrik Pedersen-Bjergaard; Ambady Ramachandran
Journal:  Diabetes Res Clin Pract       Date:  2017-05-12       Impact factor: 5.602

3.  Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network.

Authors:  Janet B McGill; Mengdi Wu; Rodica Pop-Busui; Kara Mizokami-Stout; William V Tamborlane; Grazia Aleppo; Rose A Gubitosi-Klug; Michael J Haller; Steven M Willi; Nicole C Foster; Chelsea Zimmerman; Ingrid Libman; Sarit Polsky; Michael R Rickels
Journal:  J Diabetes Complications       Date:  2019-06-26       Impact factor: 2.852

4.  Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study.

Authors:  Carlo B Giorda; Alessandro Ozzello; Sandro Gentile; Alberto Aglialoro; Anna Chiambretti; Fabio Baccetti; Francesco M Gentile; Giuseppe Lucisano; Antonio Nicolucci; Maria Chiara Rossi
Journal:  Acta Diabetol       Date:  2015-02-12       Impact factor: 4.280

5.  Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.

Authors:  B P Kovatchev; D J Cox; L A Gonder-Frederick; D Young-Hyman; D Schlundt; W Clarke
Journal:  Diabetes Care       Date:  1998-11       Impact factor: 19.112

6.  Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial.

Authors:  Zubin Punthakee; Michael E Miller; Lenore J Launer; Jeff D Williamson; Ronald M Lazar; Tali Cukierman-Yaffee; Elizabeth R Seaquist; Faramarz Ismail-Beigi; Mark D Sullivan; Laura C Lovato; Richard M Bergenstal; Hertzel C Gerstein
Journal:  Diabetes Care       Date:  2012-02-28       Impact factor: 19.112

7.  The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real-life conditions over a period of one year.

Authors:  Isabelle Paris; Corinne Henry; Françoise Pirard; Anne-Catherine Gérard; Ides M Colin
Journal:  Endocrinol Diabetes Metab       Date:  2018-06-17

8.  Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes.

Authors:  Victoria Tyndall; Roland H Stimson; Nicola N Zammitt; Stuart A Ritchie; John A McKnight; Anna R Dover; Fraser W Gibb
Journal:  Diabetologia       Date:  2019-06-09       Impact factor: 10.122

9.  Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial.

Authors:  Amit R Majithia; Coco M Kusiak; Amy Armento Lee; Francis R Colangelo; Robert J Romanelli; Scott Robertson; David P Miller; David M Erani; Jennifer E Layne; Ronald F Dixon; Howard Zisser
Journal:  J Med Internet Res       Date:  2020-08-28       Impact factor: 5.428

10.  Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic.

Authors:  Richard M Bergenstal; Jennifer E Layne; Howard Zisser; Robert A Gabbay; Nathan A Barleen; Amy Armento Lee; Amit R Majithia; Christopher G Parkin; Ronald F Dixon
Journal:  Diabetes Technol Ther       Date:  2020-11-05       Impact factor: 6.118
View more
  2 in total

1.  Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.

Authors:  Molly L Tanenbaum; Laurel H Messer; Christine A Wu; Marina Basina; Bruce A Buckingham; Danielle Hessler; Shelagh A Mulvaney; David M Maahs; Korey K Hood
Journal:  Diabetes Res Clin Pract       Date:  2021-09-14       Impact factor: 8.180

Review 2.  Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes.

Authors:  Molly L Tanenbaum; Persis V Commissariat
Journal:  Curr Diab Rep       Date:  2022-05-06       Impact factor: 5.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.